A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Conditions: Cutaneous Melanoma; Non-small Cell Lung Cancer; Colorectal Neoplasms; Pancreatic Neoplasms; Mesothelioma Intervention: Drug: SGN-BB228 Sponsor: Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2022 Category: Research Source Type: clinical trials